When Goldman reviewed the data, something became clear: reducing the burden of any one disease, even several, wouldn’t change much. “Making progress against one disease means that another will eventually emerge in its place,” his team reported in Perspectives in Medicine. “However, evidence suggests that if aging is delayed, all fatal and disabling disease risks would be lowered simultaneously.”